Global /Sweden /Healthcare /Medical Devices /QLINEA
chevron_leftBack
Q-linea AB (publ) logo

Q-linea AB (publ)

QLINEA
STO: QLINEA Delayed
18.05SEK -5.7%
1.91 USD
As of 7 June 2026, Q-linea AB (publ) has a market cap of $38.71M USD, ranking #32438 globally and #456 in Sweden. It ranks #2929 in the Healthcare sector, and #609 in the Medical Devices industry.
Global Rank
32438
Country Rank
456
Sector Rank
2929
Industry Rank
609
Key Stats
Market Cap
$38.71MUSD
362.87M SEK
Enterprise Value
$11.68MUSD
110.61M SEK
Revenue (TTM)
$2.08MUSD
19.46M SEK
EBITDA (TTM)
-$16.52MUSD
-156.49M SEK
Net Income (TTM)
-$19.47MUSD
-182.49M SEK
PS Ratio
18.6
PB Ratio
1.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Stuart Gander open_in_new
Employees
82
Founded
2007
Website
qlinea.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-5.7% -9.2% -17% -30% -23% -50%

News

Loading...

Markets

Exchange Ticker Price
Nasdaq Stockholm
MIC: XSTO
PRIMARY
QLINEA
Q-linea AB
ISIN: SE0025420714
Shares Out.:
18.949M1 Shares Float: 7.712M2
TV:
SA:
YF:
GF:
BA:
MS:
18.05 SEK
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Q-linea AB (publ)

Q-linea AB (publ) engages in the manufacturing and sale of instruments and consumables diagnose and treat infectious diseases in the United Kingdom, European Union, the Middle East, and the United States. It offers ASTar, an antimicrobial susceptibility testing (AST) technology used in the treatment of bloodstream infections and sepsis; and ASTar BC G- Kit which contains two disposables, including a sample preparation cartridge and an AST disc, used with the Frozen insert. The company also develops Podler, a portable blood culture unit for incubating and detecting growth in blood bottles. It serves physicians, hospitals, laboratories, healthcare payers, and the medical profession. The company was incorporated in 2007 and is headquartered in Uppsala, Sweden.

Similar Companies

Industry: Medical Devices (Sweden)
Name
Market Cap diff.
PE
GETI-B
$5.59B
52.4B SEK
14K%
22.2
S
SCIB
$4.85B
45.5B SEK
12K%
-
EKTA-B
$2.23B
20.86B SEK
6K%
-
$1.59B
14.87B SEK
4K%
-
$1.53B
14.32B SEK
4K%
78.5
$907.38M
8.5B SEK
2K%
115.1
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
$173.27B
447K%
25.8
$160.73B
415K%
56.7
$159.07B
411K%
25.6
DHR
$126.55B
327K%
34.7
SYK
$120.69B
312K%
38.3
MDT
$101.9B
263K%
22.2
chevron_leftBack